Specific topics addressed in the slides to follow include:
- Update on the endothelium
- Interactions of the RAS: ACE and the angiotensin II and bradykinin pathways
- Correlates of endothelial function and cardiovascular risk
- Hypertension: A new treatment approach
- Heart failure: Role of ACE inhibition
- Differentiating among ACE inhibiting agents
- Status report on ACE and angiotensin II type 1 receptor blockade
- The tissue ACE trials